Allergy

 
Study Finds Dupilumab Effective for Severe Atopic Dermatitis in Real-world Setting
February 27, 2021

Dupilumab therapy for 4 weeks in adults with severe atopic dermatitis resulted in significant improvements in clinical outcomes with no adverse events reported.

FDA Approves First Drug for the Treatment of Peanut Allergy in Children
February 03, 2020

The first and only drug to treat peanut allergy recently received approval, giving the growing number of patients a new treatment option.

Hygiene and Health: 8 Pristine Questions
May 02, 2019

Sample: The hygiene hypothesis states that early exposure to germs reduces the immune system’s ability to resist infections in later years. True or false?